Group One Trading
CLVS

Group One Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Group One Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-237,835
Closed -$371K – 8568
2022
Q2 		$428K Sell
237,835
-16,097
-6% -$23.7K ﹤0.01% 3579
2022
Q1 		$513K Buy
253,932
+4,582
+2% +$9K ﹤0.01% 3786
2021
Q4 		$676K Sell
249,350
-84,517
-25% -$312K ﹤0.01% 3772
2021
Q3 		$1.49M Buy
333,867
+28,708
+9% +$138K ﹤0.01% 2968
2021
Q2 		$1.77M Buy
305,159
+44,122
+17% +$259K ﹤0.01% 2792
2021
Q1 		$1.83M Sell
261,037
-68,072
-21% -$456K ﹤0.01% 2559
2020
Q4 		$1.58M Buy
329,109
+145,290
+79% +$735K ﹤0.01% 2243
2020
Q3 		$1.07M Buy
+183,819
New +$1.1M ﹤0.01% 2132
2019
Q3 		– Sell
-28,174
Closed -$228K – 5711
2019
Q2 		$419K Sell
28,174
-15,733
-36% -$284K ﹤0.01% 2291
2019
Q1 		$1.09M Sell
43,907
-378
-0.9% -$9.48K 0.01% 1348
2018
Q4 		$795K Buy
44,285
+23,481
+113% +$480K 0.01% 1671
2018
Q3 		$611K Sell
20,804
-5,300
-20% -$205K ﹤0.01% 2123
2018
Q2 		$1.19M Sell
26,104
-4,678
-15% -$228K 0.01% 1553
2018
Q1 		$1.63M Buy
30,782
+4,586
+18% +$268K 0.02% 1152
2017
Q4 		$1.78M Sell
26,196
-79,204
-75% -$5.54M 0.01% 1268
2017
Q3 		$8.69M Buy
105,400
+19,589
+23% +$1.55M 0.08% 306
2017
Q2 		$8.03M Buy
85,811
+42,648
+99% +$2.61M 0.08% 282
2017
Q1 		$2.75M Buy
43,163
+40,497
+1,519% +$2.46M 0.03% 668
2016
Q4 		$118K Sell
2,666
-1,488
-36% -$52.4K ﹤0.01% 2747
2016
Q3 		$150K Buy
+4,154
New +$89.1K ﹤0.01% 2671
2016
Q2 		– Sell
-18,816
Closed -$275K – 5042
2016
Q1 		$361K Sell
18,816
-11,581
-38% -$245K 0.01% 1931
2015
Q4 		$1.06M Buy
30,397
+7,420
+32% +$479K 0.01% 1276
2015
Q3 		$2.11M Buy
+22,977
New +$1.99M 0.03% 752
2014
Q3 		– Sell
-6,666
Closed -$278K – 5562
2014
Q2 		$276K Sell
6,666
-2,535
-28% -$131K ﹤0.01% 2123
2014
Q1 		$637K Buy
9,201
+4,747
+107% +$349K 0.01% 1452
2013
Q4 		$268K Buy
+4,454
New +$242K ﹤0.01% 2178

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Group One Trading's CLVS Position: Q3 2022 in Review

Group One Trading sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 237,835 shares — an estimated $371K sold.

Group One Trading first reported a position in CLVS in Q4 2013 and held it in 26 quarters. The position peaked at $8.69M in Q3 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Group One Trading reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 237,835 Clovis Oncology, Inc. shares in Q3 2022, an estimated $371K.
  • Group One Trading first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 26 quarters.
  • Group One Trading's Clovis Oncology, Inc. position peaked at $8.69M in Q3 2017.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.